Short Interest Screener
Find squeeze candidates or browse the raw short-interest tape. Bi-weekly cadence — settlement dates typically lag by ~10 business days.
Screener results are algorithmic and for informational purposes only. Squeeze scores do not constitute trading recommendations. Short-interest data has an inherent ~2-week reporting lag. See Terms §17.
Mode
Matches
—
Symbols passing filters
Avg SI % Float
—
Across matched symbols
Avg Days-to-Cover
—
Across matched symbols
Avg 20d Return
—
Across matched symbols
Squeeze Rank
| Symbol | Name | Score ↕ | SI % Float | Δ SI % | DTC | SI Shares | Market Cap | SV % | 20d Return | 5d Return | Price | Settlement | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAE | CAE Inc. Common Shares | 84954.29 | 13371.0% | +805.7pp | 8.2 | 5,557,253 | $7.8B | 8199.0% | -11.4% | 2.1% | $24.06 | 2026-08-14 | |
| GIL | Gildan Activewear Inc. | 39492.33 | 5799.0% | +1081.9pp | 9.4 | 11,979,531 | $9.5B | 5346.0% | -13.8% | 0.4% | $50.45 | 2026-08-14 | |
| HPK | HighPeak Energy, Inc. Common Stock | 1271.11 | 80.5% | +13.0pp | 16.0 | 9,303,574 | $1.0B | 5319.0% | -0.6% | 1.2% | $8.21 | 2026-08-14 | |
| PLCE | Children's Place, Inc. | 1015.45 | 50.4% | -0.9pp | 21.7 | 3,411,565 | $62M | 5812.0% | 0.4% | 1.2% | $2.54 | 2026-08-14 | |
| LENZ | LENZ Therapeutics, Inc. Common Stock | 881.26 | 79.5% | -0.9pp | 12.5 | 11,195,137 | $167M | 6383.0% | -5.8% | -6.1% | $4.91 | 2026-08-14 | |
| FDMT | 4D Molecular Therapeutics, Inc. Common Stock | 812.82 | 27.6% | +0.6pp | 22.3 | 12,289,621 | $808M | 7843.0% | 23.6% | -1.2% | $14.18 | 2026-08-14 | |
| ZBIO | Zenas BioPharma, Inc. Common Stock | 792.57 | 40.0% | -0.3pp | 21.1 | 11,658,986 | $2.2B | 6159.0% | -0.5% | 1.0% | $32.29 | 2026-08-14 | |
| CHPT | ChargePoint Holdings, Inc. | 728.4 | 25.2% | +2.3pp | 15.6 | 5,757,348 | $252M | 4144.0% | 42.7% | 68.9% | $8.95 | 2026-08-14 | |
| INBX | Inhibrx Biosciences, Inc. Common Stock | 718.64 | 34.6% | -1.4pp | 14.4 | 3,215,230 | $1.7B | 6292.0% | 22.2% | -9.5% | $112.86 | 2026-08-14 | |
| NTST | NetSTREIT Corp. | 655.97 | 32.3% | -0.2pp | 27.9 | 31,209,261 | $2.1B | 3569.0% | 0.8% | -2.0% | $20.04 | 2026-08-14 | |
| GALT | Galectin Therapeutics Inc. | 654.57 | 20.6% | +0.7pp | 21.6 | 9,002,474 | $418M | 7964.0% | 29.4% | -2.9% | $4.05 | 2026-08-14 | |
| NVAX | Novavax Inc | 629.98 | 30.4% | +1.2pp | 14.0 | 47,494,355 | $1.7B | 5362.0% | 23.9% | -2.7% | $9.85 | 2026-08-14 | |
| MPW | Medical Properties Trust, Inc. | 606.36 | 30.3% | -0.1pp | 24.1 | 150,604,080 | $3.0B | 6364.0% | — | — | — | 2026-01-30 | |
| PROK | ProKidney Corp. Class A Ordinary Shares | 593.72 | 24.4% | +0.9pp | 18.7 | 21,494,435 | $416M | 6204.0% | 14.9% | 0.0% | $1.85 | 2026-08-14 | |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 565.06 | 28.7% | -3.0pp | 9.9 | 6,526,090 | $444M | 5499.0% | 96.0% | -9.2% | $14.74 | 2026-08-14 | |
| BMEA | Biomea Fusion, Inc. Common Stock | 561.52 | 15.1% | -0.3pp | 20.9 | 9,820,656 | $140M | 6236.0% | 43.0% | 2.5% | $1.84 | 2026-08-14 | |
| IBRX | ImmunityBio, Inc. Common Stock | 558.69 | 32.3% | -0.4pp | 15.4 | 127,495,672 | $8.8B | 6276.0% | 6.1% | 2.4% | $8.06 | 2026-08-14 | |
| TNGX | Tango Therapeutics, Inc. | 550.79 | 33.5% | -1.1pp | 20.9 | 43,186,169 | $3.8B | 4383.0% | -8.9% | 7.4% | $24.00 | 2026-08-14 | |
| PRME | Prime Medicine, Inc. Common Stock | 540.5 | 34.6% | +0.0pp | 13.8 | 35,022,290 | $646M | 4552.0% | 6.4% | -2.8% | $3.47 | 2026-08-14 | |
| UPXI | Upexi, Inc. Common Stock | 536.47 | 21.2% | -0.6pp | 16.0 | 15,076,502 | $76M | 2970.0% | 29.0% | -0.5% | $1.03 | 2026-08-14 | |
| NGNE | Neurogene, Inc. Common Stock | 533.87 | 28.5% | +0.3pp | 16.8 | 3,038,441 | $763M | 6379.0% | 5.8% | 0.0% | $37.88 | 2026-08-14 | |
| NTLA | Intellia Therapeutics, Inc | 530.69 | 39.1% | +0.8pp | 13.2 | 44,880,339 | $1.8B | 5071.0% | 1.6% | -3.7% | $12.21 | 2026-08-14 | |
| VOR | Vor Biopharma Inc. Common Stock | 530.62 | 55.6% | +0.7pp | 9.8 | 7,350,765 | $1.5B | 5974.0% | -1.5% | 2.6% | $23.23 | 2026-08-14 | |
| XRX | Xerox Holdings Corporation Common Stock | 521.29 | 34.6% | +1.2pp | 15.9 | 39,150,216 | $420M | 6280.0% | -2.5% | -0.6% | $3.14 | 2026-08-14 | |
| CBIO | Crescent Biopharma, Inc. Common Stock | 519.04 | 21.7% | -1.7pp | 17.1 | 3,216,698 | $760M | 5857.0% | 19.8% | 11.5% | $19.99 | 2026-08-14 | |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | 503.82 | 41.0% | -0.7pp | 13.4 | 177,923,359 | $1.8B | 5834.0% | -4.0% | -3.5% | $3.21 | 2026-08-14 | |
| SVRA | Savara Inc. | 496.55 | 26.3% | +1.2pp | 27.1 | 38,505,948 | $1.1B | 7308.0% | -2.8% | 1.2% | $5.42 | 2026-08-14 | |
| IRD | Opus Genetics, Inc. Common Stock | 494.2 | 16.5% | +0.6pp | 15.3 | 11,248,349 | $361M | 5245.0% | 47.7% | 49.6% | $5.73 | 2026-08-14 | |
| SLDB | Solid Biosciences Inc. Common Stock | 492.37 | 21.7% | -0.5pp | 19.6 | 16,619,915 | $1.1B | 6898.0% | 7.8% | -3.4% | $9.54 | 2026-08-14 | |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | 483.81 | 28.0% | +4.7pp | 19.8 | 20,477,587 | $391M | 6323.0% | -6.3% | -4.7% | $4.48 | 2026-08-14 | |
| AI | C3.ai, Inc. | 482.96 | 44.2% | +1.7pp | 11.5 | 48,144,524 | $1.7B | 5167.0% | -2.4% | 0.4% | $10.38 | 2026-08-14 | |
| PTN | Palatin Technologies, Inc. Common Stock | 480.98 | 21.4% | +3.2pp | 11.3 | 349,501 | $23M | 5245.0% | 66.4% | 6.8% | $12.33 | 2026-08-14 | |
| AVBP | ArriVent BioPharma, Inc. Common Stock | 471.44 | 26.2% | +0.6pp | 21.8 | 8,227,393 | $1.5B | 6747.0% | -5.1% | -1.2% | $29.79 | 2026-08-14 | |
| IPSC | Century Therapeutics, Inc. Common Stock | 463.85 | 23.9% | -0.4pp | 51.2 | 29,370,152 | $375M | 4766.0% | -1.5% | 0.0% | $2.03 | 2026-08-14 | |
| IMRX | Immuneering Corporation Class A Common Stock | 459.84 | 25.8% | -1.7pp | 19.4 | 14,426,945 | $309M | 4003.0% | -4.0% | -4.9% | $4.61 | 2026-08-14 | |
| RENT | Rent the Runway, Inc. Class A Common Stock | 458.36 | 35.2% | -4.1pp | 34.2 | 1,241,321 | $107M | 7764.0% | -17.4% | -18.8% | $3.00 | 2026-08-14 | |
| SLS | SELLAS Life Sciences Group, Inc. Common Stock | 450.29 | 28.3% | +0.7pp | 10.4 | 56,371,865 | $2.8B | 5828.0% | 26.2% | 5.5% | $13.95 | 2026-08-14 | |
| ABSI | Absci Corporation Common Stock | 450.22 | 35.4% | +0.1pp | 15.2 | 37,417,586 | $1.5B | 6233.0% | -8.1% | -2.1% | $8.65 | 2026-08-14 | |
| CRK | Comstock Resources, Inc. | 448.21 | 31.3% | -0.4pp | 13.4 | 24,575,628 | $4.5B | 4468.0% | 3.5% | -7.0% | $14.90 | 2026-08-14 | |
| CAR | Avis Budget Group, Inc. | 441.12 | 31.5% | -0.5pp | 15.8 | 5,447,674 | $4.7B | 8324.0% | -5.7% | -5.7% | $132.63 | 2026-08-14 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 440.51 | 27.2% | +1.2pp | 22.5 | 19,127,098 | $1.2B | 3036.0% | -9.5% | -6.6% | $13.33 | 2026-08-14 | |
| AVTX | Avalo Therapeutics, Inc. Common Stock | 439.98 | 25.3% | +0.3pp | 20.2 | 13,092,767 | $1.1B | 5402.0% | -6.5% | -3.9% | $18.21 | 2026-08-14 | |
| BEAM | Beam Therapeutics Inc. Common Stock | 430.17 | 30.6% | +1.1pp | 16.1 | 24,374,054 | $2.8B | 6567.0% | -6.2% | -13.2% | $25.18 | 2026-08-14 | |
| CHRS | Coherus Oncology, Inc. Common Stock | 428.77 | 18.4% | -0.4pp | 19.7 | 23,997,214 | $212M | 6721.0% | 9.1% | -3.6% | $1.32 | 2026-08-14 | |
| MPT | Medical Properties Trust, Inc. | 427.18 | 29.2% | +0.0pp | 15.6 | 144,500,823 | $2.4B | 7556.0% | -3.0% | -3.2% | $3.90 | 2026-08-14 | |
| RLAY | Relay Therapeutics, Inc. Common Stock | 423.12 | 24.4% | +0.7pp | 21.6 | 41,359,202 | $4.2B | 7787.0% | -6.7% | 0.9% | $18.66 | 2026-08-14 | |
| CABA | Cabaletta Bio, Inc. Common Stock | 421.52 | 31.3% | +1.5pp | 12.4 | 42,795,914 | $554M | 4266.0% | 4.3% | -11.8% | $2.91 | 2026-08-14 | |
| CCCC | C4 Therapeutics, Inc. | 414.41 | 38.2% | +4.1pp | 13.9 | 34,048,321 | $437M | 5249.0% | -11.1% | -11.1% | $3.44 | 2026-08-14 | |
| HRTX | Heron Therapeutics, Inc. | 409.42 | 31.4% | +2.3pp | 12.3 | 46,738,152 | $66M | 6062.0% | 2.8% | 5.7% | $0.33 | 2026-08-14 | |
| ANAB | AnaptysBio, Inc. Common Stock | 407.36 | 30.8% | -0.5pp | 14.3 | 5,317,981 | $1.7B | 6207.0% | -3.7% | 0.8% | $55.70 | 2026-08-14 |
Reading This Screener
Two Modes
- Squeeze Rank: Composite score =
SI %-of-float × min(DTC, 20) × momentum multiplier. Momentum multiplier ranges 0.5x–2x based on the 20-day return — positive returns amplify the score because shorts are already bleeding. Best signal when the "Require +20d return" filter is on. - Data Browser: The unopinionated table sorted by SI %-of-float. Turn off "Require +20d return" and set Min DTC to 0.5 for the widest view.
The Fields
- SI %-of-Float: Short shares divided by free float. Anything over 20% is aggressive; over 30% is squeeze territory.
- Δ SI %: Change since the prior report (~2 weeks earlier). Rising = more shorts piling on; falling = covering.
- DTC (Days-to-Cover): Short shares divided by average daily volume. Higher = harder to close positions without moving price.
- SV % (Short Volume %): From the daily consolidated tape — how much of today's volume was short-side. Updated daily, unlike SI which is bi-weekly.
- 20d Return: Positive return on a high-SI name = short book is already under water. That's fuel.
Data Cadence
Short interest is published twice a month with a ~10-business-day lag. The daily "SV %" column is a much fresher proxy for short-side conviction. Free-float is refreshed from public issuer filings when they change.